Axicabtagene Ciloleucel
Common brands: Yescarta, Cyclophosphamide, Frindovyx, Fludarabine, Rituxan
Top reporter: Kite Pharma, Inc.
CD19-directed Chimeric Antigen Receptor [EPC]Genetically-modified Autologous T Cells [EPC]Alkylating Drug [EPC]Corticosteroid [EPC]CD20-directed Cytolytic Antibody [EPC]
9,420
Total Reports
7,015
Serious Reports
2,499
Death Reports
30
Reported Reactions
Death Report Ratio: High (26.53%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Axicabtagene Ciloleucel.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | CYTOKINE RELEASE SYNDROME | 4,375 | |
| 2 | IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME | 1,981 | |
| 3 | NEUROTOXICITY | 1,363 | |
| 4 | DEATH | 925 | |
| 5 | PYREXIA | 891 | |
| 6 | DISEASE PROGRESSION | 785 | |
| 7 | NEUTROPENIA | 471 | |
| 8 | HYPOTENSION | 388 | |
| 9 | DIFFUSE LARGE B-CELL LYMPHOMA | 363 | |
| 10 | CONFUSIONAL STATE | 299 | |
| 11 | FEBRILE NEUTROPENIA | 293 | |
| 12 | ENCEPHALOPATHY | 286 | |
| 13 | DRUG INEFFECTIVE | 269 | |
| 14 | MYELODYSPLASTIC SYNDROME | 261 | |
| 15 | FATIGUE | 258 | |
| 16 | PANCYTOPENIA | 256 | |
| 17 | THROMBOCYTOPENIA | 251 | |
| 18 | APHASIA | 237 | |
| 19 | TREMOR | 227 | |
| 20 | ANAEMIA | 219 | |
| 21 | HYPOXIA | 211 | |
| 22 | HEADACHE | 189 | |
| 23 | CYTOPENIA | 187 | |
| 24 | OFF LABEL USE | 182 | |
| 25 | PNEUMONIA | 182 | |
| 26 | NEUTROPHIL COUNT DECREASED | 181 | |
| 27 | PLATELET COUNT DECREASED | 178 | |
| 28 | TACHYCARDIA | 178 | |
| 29 | ASTHENIA | 162 | |
| 30 | SOMNOLENCE | 157 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.